home.social

#globalpayments — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #globalpayments, aggregated by home.social.

  1. Ebury, Santander’s International Payments Fintech, Secures C.£550 Million to Accelerate Growth and Global Expansion

    WHY THIS MATTERS: The c.£550 million funding injection for Ebury, spearheaded by Santander and Centerbridge Partners, represents a…
    #Spain #ES #Europe #Europa #EU #BancoSantander #AIcapabilities #cross-borderpayments #ebury #fundinground #Globalpayments #internationaltrade #paymentprocessing #payments #Santander
    europesays.com/spain/14430/

  2. Standardized payment data formats are enabling interoperability across global fintech systems, reducing cross-border friction.

    #ISO20022 #GlobalPayments

  3. Standardized payment data formats are enabling interoperability across global fintech systems, reducing cross-border friction.

    #ISO20022 #GlobalPayments

  4. Standardized payment data formats are enabling interoperability across global fintech systems, reducing cross-border friction.

    #ISO20022 #GlobalPayments

  5. Standardized payment data formats are enabling interoperability across global fintech systems, reducing cross-border friction.

    #ISO20022 #GlobalPayments

  6. New Payment Options – Lower Fees & Easier Checkout

    We’re pleased to announce that SecPoint has upgraded our payment setup to a new, modern payment platform, offering:

    Customers can now pay easily using Visa, Mastercard, AmEx, Diners Club, JCB, and other widely used international cards.

    Login now at: vip.secpoint.com

    #SecPoint #Payments #OnlinePayments #SecurePayments #Ecommerce #CyberSecurity #BusinessSecurity #GlobalPayments #B2B

  7. Zimmer Biomet ($ZBH) reported EPS of $1.74, matching the forecast of $1.74. Revenue was $1.82B, slightly exceeding the expected $1.8B.

    Global Payments ($GPN) achieved EPS of $3.08, just below the forecast of $3.09. Revenue reached $2.6B, surpassing the anticipated $2.38B.

    Biogen ($BIIB) posted EPS of $4.08, exceeding the forecast of $3.77. Revenue was $2.47B, slightly above the expected $2.43B.

    #Earnings #Q3 #ZimmerBiomet #GlobalPayments #Biogen #Investing #Finance #Stocks #MarketNews

  8. Zimmer Biomet ($ZBH) reported EPS of $1.74, matching the forecast of $1.74. Revenue was $1.82B, slightly exceeding the expected $1.8B.

    Global Payments ($GPN) achieved EPS of $3.08, just below the forecast of $3.09. Revenue reached $2.6B, surpassing the anticipated $2.38B.

    Biogen ($BIIB) posted EPS of $4.08, exceeding the forecast of $3.77. Revenue was $2.47B, slightly above the expected $2.43B.

    #Earnings #Q3 #ZimmerBiomet #GlobalPayments #Biogen #Investing #Finance #Stocks #MarketNews

  9. Zimmer Biomet ($ZBH) reported EPS of $1.74, matching the forecast of $1.74. Revenue was $1.82B, slightly exceeding the expected $1.8B.

    Global Payments ($GPN) achieved EPS of $3.08, just below the forecast of $3.09. Revenue reached $2.6B, surpassing the anticipated $2.38B.

    Biogen ($BIIB) posted EPS of $4.08, exceeding the forecast of $3.77. Revenue was $2.47B, slightly above the expected $2.43B.

    #Earnings #Q3 #ZimmerBiomet #GlobalPayments #Biogen #Investing #Finance #Stocks #MarketNews

  10. Zimmer Biomet ($ZBH) reported EPS of $1.74, matching the forecast of $1.74. Revenue was $1.82B, slightly exceeding the expected $1.8B.

    Global Payments ($GPN) achieved EPS of $3.08, just below the forecast of $3.09. Revenue reached $2.6B, surpassing the anticipated $2.38B.

    Biogen ($BIIB) posted EPS of $4.08, exceeding the forecast of $3.77. Revenue was $2.47B, slightly above the expected $2.43B.

    #Earnings #Q3 #ZimmerBiomet #GlobalPayments #Biogen #Investing #Finance #Stocks #MarketNews